Global Health

“ACT Consortum” Investigates Millions of Lives At Stake From Substandard, Degraded And Fake Anti-Malarial Drugs

November 18, 2009
Harparkash Kaur

Harparkash Kaur

The problem of artemisinin combination treatments (ACTs) in malaria which are ineffective because of poor storage, manufacture, or criminal counterfeiting was addressed in Nairobi at the 5th Multilateral Initiative On Malaria Pan African Malaria Conference by Harparkash Kaur of the London School of Hygiene and Tropical Medicine—a member of the recently-formed: ACT Consortium. After her talk she discussed her data and the efforts the consortium is making to resolve the issue with Peter Goodwin.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Audio Journal of Global Health Issues: Counterfeit Anti-Infective Drugs: A Huge Problem, Often Overlooked

    • PAUL NEWTON, Centre for Clinical Vaccinology and Tropical Medicine, Oxford REFERENCE: Lancet Infect Dis 2006; 6:602-13 No one knows the exact proportion

  • Scientifically Designed Healthcare Tailored To Patients’ Needs Saves Lives

    • New ways of delivering healthcare — discussed at a conference in London — promise to save millions of lives

  • New Ways Of Using Malaria Drugs Bring Promise For Control

    • [caption id="attachment_1014" align="alignnone" width="120" caption="Brian Greenwood"][/caption] Brian Greenwood, Professor of Tropical Medicine at The London School of Hygiene and Tropical

    Post a comment